Improved physical stability of docosahexaenoic acid and eicosapentaenoic acid encapsulated using nanoliposome containing α‐tocopherol

This study aimed to develop a nanoliposomal formulation containing α‐tocopherol loaded with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and to characterise the formulation by its physical stability. For this purpose, different nanoliposomal formulations with dipalmitoyl phosphocholine were prepared using a modified thin‐film hydration method and evaluated by particle size, polydispersity index (PDI), transmission electron microscopy, differential scanning calorimetry and determining the encapsulation efficiencies of DHA and EPA. A physical stability study was conducted by investigating the change in the vesicle encapsulation efficiency, particle size, PDI and shape when stored at 4, 30 and 40 °C for 3 months. High encapsulation efficiency of DHA and EPA (89.1% ± 0.6% and 81.9% ± 1.4%) and appropriate particle size (82 ± 0.8 nm) were obtained for liposomes composed of α‐tocopherol. The optimum formulation was stable for 90 days when kept at 4 °C. This study demonstrated that α‐tocopherol had a protective effect on the physical stability of the nanoliposomes containing DHA and EPA.     

A comparative study of ZrO2, Y2O3 and Sm2O3 promoted Ni/SBA-15 catalysts for evaluation of CO2/methane reforming performance

Ni-based/SBA-15 catalysts, were promoted by 3wt % of samaria (Sm₂O₃), Yttria (Y₂O₃) and Zirconia (ZrO₂), by two-solvent impregnation method. The catalysts characterization was performed by N2 adsorption–desorption, X-ray Diffraction (XRD), X-ray Fluorescence (XRF), High Resolution Transmission Electron Microscopy (HRTEM), Field Emission Electron Scanning Microscopy (FESEM), Temperature Programmed Oxidation/Reduction (TPO/TPR) and NH₃-Temperature Programmed Desorption (NH₃-TPD) techniques. Then, evaluated by CO₂/methane reforming.The CO₂/methane reforming outcomes revealed that samaria-promoted catalyst showed excellent activity, stability and cock resistance, while yttria-promoted catalyst just illustrated good activity at high temperature and zirconia-promoted catalyst didn't show any modification in catalytic performance in comparison to Ni-based catalyst with no promoter. Samaria-promoted TEM and TPR analysis, indicated adding samaria improved the NiO particles interaction with SBA-15 support pores wall and NiO dispersion. The TPO analysis displayed that coke deposition in samaria-promoted sample after 12 h reaction is less than yttria-promoted during stream of 5 h. Also, it is suggested that for samaria containing catalyst, cock deposition occurred on the support. Therefore, nickel active sites were preserved for time on stream of 12 h, which is the main reason for samaria-promoted catalyst superior stability than other's.     

Detection of individual activities in video sequences based on fast interference discovery and semi-supervised method

Multimedia Tools and Applications - Auto understanding of human activities in video is an increasing necessity in some application realms. The existing methods for human’s activity...     

No-chatter model-free sliding mode control for synchronization of chaotic fractional-order systems with application in image encryption

Multimedia Tools and Applications - Synchronization of different Chaotic dynamical systems is one of the main issues in engineering which has a lot of applications in applied sciences like secure...     

Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer

Non-small cell lung cancer (NSCLC) patients with sensitizing mutations in the exons 18–21 of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR. Hence, tyrosine kinase inhibitors (TKIs) such as erlotinib (ETB) have commonly been used as the second line therapeutic option for the treatment of metastatic NSCLC. While the ETB is available as an oral dosage form, the local delivery of this TKI to the diseased cells of the lung may ameliorate its therapeutic impacts. In the current study, we report on the development of ETB-loaded solid lipid nanoparticle (SLN) based formulation of dry powder inhaler (ETB-SLN DPI). ETB-SLNs were formulated using designated amount of compritol/poloxamer 407. The engineered ETB-SLNs showed sub-100?nm spherical shape with an encapsulation efficiency of 78.21%. MTT assay and DAPI staining revealed that the ETB-SLNs enhanced the cytotoxicity of cargo drug molecules in the human alveolar adenocarcinoma epithelial A549 cells as a model for NSCLC. To attain the ETB-SLN DPI, the ETB-SLNs were efficiently spray dried into microparticles (1–5?μm) along with mannitol. The ETB-SLN DPI powder displayed suitable flowability and aerodynamic traits. The Carr's Index, Hausner ratio and Next Generation Impactor (NGI) analyses confirmed deep inhalation pattern of the formulation. Based on these findings, we propose the ETB-SLN DPI as a promising treatment modality for the NSCLC patients.